SCHEMBL1366604

SCHEMBL1366604

COc1cc(OC)c2cc(C(=O)/C=C/c3ccc(Cl)cc3)c(=O)sc2c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 9/20 0.63
MAOB P27338 5/20 0.54
MAPT P10636 3/20 0.52
TNFRSF1A P19438 1/20 0.52
MAOA P21397 2/20 0.50
XDH P47989 1/20 0.49
AR P10275 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
USP2 O75604 1/20 0.47
MAPK1 P28482 1/20 0.47
TLR9 Q9NR96 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NFKB1 P19838 1/20 0.46
DPP4 P27487 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1366605 1.00 ABCG2 (0.63) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1366898 1.00 ABCG2 (0.63) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1367704 0.93 ABCG2 (0.60) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1367943 0.93 ABCG2 (0.60) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1367706 0.93 ABCG2 (0.60) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1368084 0.88 MAPT (0.52) ABCG2MAPTMEN1KMT2ANPC1
SCHEMBL1368568 0.88 MAPT (0.52) ABCG2MAPTMEN1KMT2ANPC1
SCHEMBL1368087 0.88 MAPT (0.52) ABCG2MAPTMEN1KMT2ANPC1
SCHEMBL1367949 0.82 ABCG2 (0.62) ABCG2MAOBMAPTTNFRSF1AMAOA
SCHEMBL1367951 0.82 ABCG2 (0.62) ABCG2MAOBMAPTTNFRSF1AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS ABCG2 57/4885MAOB 2929/4885MAPT 4718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.